Pramiracetam

Nootropic

Memory and focus positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Racetam
Primary mechanism: Cholinergic/racetam modulation
Primary market use: Cognition

Pharmacology

Molecular weight (Da): 269.3
Oral bioavailability: Oral; % not established
Half-life: ~4-6 h
Route tags: Route-dependent / verify
Evidence level: Human/research
Clinical status: Research/regional
Value-for-money score: 5 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Requires ongoing dosing

Sources

https://pubmed.ncbi.nlm.nih.gov/